CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to REPL

RP1, intra-tumoral injection, oncolytic virus

Phase 2
Replimune Group, Inc. (REPL)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '27
REPLPhase 2

RP1, intra-tumoral injection, oncolytic virus Phase 2 Est. Readout

RP1, intra-tumoral injection, oncolytic virus
Sep 2027~STALE
CT.gov
00%
Competitive Landscape

0 competitors in Cutaneous Squamous Cell Carcinoma

View Full Landscape
Drug Information

Target Indication

Cutaneous Squamous Cell Carcinoma

Clinical Trial

NCT04349436

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.